A. Thomas McLellan, PhD, former deputy director of the Office of National Drug Control Policy (ONDCP) in the White House and a recognized addiction treatment researcher, has been elected by unanimous vote to the Board of Directors of the Betty Ford Center, the non-profit addiction treatment hospital located in Rancho Mirage, California. His election was announced by by board chair Dr. Mary Pattiz and the Betty Ford Center CEO, John Schwarzlose.
Prior to serving in the White House, Dr. McLellan was a psychologist and professor of psychiatry at the University of Pennsylvania and founder and executive director of the Treatment Research Institute, a not-for-profit research and evaluation operation based in Philadelphia. He was the principal developer of the Addiction Severity Index (ASI) and the Treatment Services Review (TSR), measurement instruments that characterize the multiple dimensions of substance abusing patients and treatment protocols. These tools have been translated into over 20 languages and are the most widely used instruments of their kind in the world.
Dr. McLellan’s work has also promoted better understanding of the factors that lead to treatment success, and has fostered greater understanding of addiction as a chronic, complex, biological and psychological illness. He has published more than 400 articles on addiction research and served as editor-in-chief of the
Journal of Substance Abuse Treatment. Among his many honors are the Life Achievement Award of the Society of Addiction Medicine.